84 parallel-processing-bioinformatics Postdoctoral positions at University of Oxford in Uk
-
to meet deadlines. The post will be based in the Department of Chemistry, Physical and Theoretical Chemistry Laboratory and is available from November 2025. Application Process Applications for this vacancy
-
sports clubs for those looking for more than just a great place to work. Application Process Applications for this vacancy are to be made online via www.recruit.ox.ac.uk and Vacancy ID 182767 . You will be
-
the Department of Chemistry, Inorganic Chemistry Laboratory, South Parks Road, OX1 3QR and is available from 1 January 2026. Application Process Applications for this vacancy are to be made online and you will be
-
motivated Postdoctoral Researcher with expertise in bioconjugate chemistry to develop next-generation delivery platforms for nucleic acid therapeutics. Application Process You will be required to upload a CV
-
will be involved in processing and analysing tissue collected from patients undergoing surgery, using whole genome sequencing, transcriptomics and proteomics. You will be heavily involved in designing
-
background, with at least one recent publication in an internationally reputable journal. Application Process You will be required to upload a covering letter/supporting statement, CV and the details of two
-
). Application Process Applications for this vacancy are to be made online and you will be required to upload a supporting statement and CV as part of your application. In your supporting statement (no more than
-
essential as is the ability to work effectively independently and collaboratively. Diversity Committed to equality and valuing diversity Application Process You will be required to upload a covering letter
-
relating to data processing and analysis. A forward-thinking, collaborative approach to research will be essential to meet the aims of the partnership. Applications for this vacancy should be made online and
-
About the role The Lu lab is interested in the mechanism by which cancer karyotype mutates and becomes resistant to therapy, with the aim of finding new ways to treat cancer more effectively. We